Skip to main content
Quratis Inc. logo

Quratis Inc. — Investor Relations & Filings

Ticker · 348080 ISIN · KR7348080003 KO Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2026-03-20 Major Shareholding Noti…
Country KR South Korea
Listing KO 348080

About Quratis Inc.

https://www.quratis.com

Quratis Inc. is a biopharmaceutical company specializing in the research and development of vaccines and therapeutic agents for infectious diseases. The company's lead pipeline candidate is QTP101, a novel tuberculosis (TB) vaccine developed for adolescents and adults, an area with significant unmet medical needs. Quratis operates its own GMP-certified manufacturing facility, enabling the production of various biologics such as DNA plasmids, RNA, and proteins to support its development programs. The company is advancing the global commercialization of its TB vaccine through strategic partnerships and technology transfers, with notable progress in key Asian markets.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act in South Korea. This type of filing is used to notify the market when a shareholder's stake in a company crosses significant thresholds (e.g., 5% rule). In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2026-03-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. It details a change in shareholding by a major shareholder (Inventage Lab Inc.) in the issuer (Curatis). This type of filing is specifically designed to report changes in significant share ownership levels, which aligns with the 'Major Shareholding Notification' category.
2026-03-20 Korean
[기재정정]감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled 'Audit Report Submission' (감사보고서 제출) and specifically marked as a 'Correction Report' (정정신고). It provides updated financial data, including balance sheet figures and loss ratios, following a revision to the previously submitted audit report. Since this is a formal regulatory disclosure regarding the submission and correction of audit-related financial information rather than the full audit report document itself, it falls under the category of Audit Report / Information. FY 2024
2026-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from the company QURATIS. It provides the auditor's opinion, financial highlights, and key accounting metrics for the fiscal year ending 2025-12-31. While it contains financial data, it is a standard regulatory disclosure of the audit results rather than the full 10-K annual report or a standalone audit report document. Given the specific nature of the filing as a regulatory submission of audit results, it falls under the 'Audit Report / Information' category. FY 2025
2026-03-18 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Quratis Inc. It contains the meeting date, location, agenda items (financial statement approval, director appointments, remuneration limits), and detailed management reference materials (business overview, market analysis, and pipeline status). This document is a standard proxy statement/notice package provided to shareholders ahead of an AGM.
2026-03-16 Korean
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice regarding the convocation of a General Meeting of Shareholders (주주총회소집결의) for the company QURATIS. It details the agenda, meeting date, location, and specific proposals such as the approval of financial statements and the appointment of directors. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement (PSI) category.
2026-03-16 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.